A de St Maurice1,2, E Ervin1, R Orone3, M Choi1, E K Dokubo4, P E Rollin1, S T Nichol1, D Williams4, J Brown3, R Sacra3, J Fankhauser3, B Knust1. 1. Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Pediatric Infectious Diseases, University of California Los Angeles, Los Angeles, California. 3. ELWA Hospital, Monrovia, Liberia. 4. Centers for Disease Control and Prevention, Monrovia, Liberia.
Abstract
BACKGROUND: The Eternal Love Winning Africa (ELWA) Clinic was the first clinic to provide free, comprehensive care to Ebola virus disease (EVD) survivors in Liberia. The objectives of this analysis were to describe the demographics and symptoms of EVD survivors at ELWA from January 2015 through March 2017 and to identify risk factors for development of sequelae. METHODS: Patients' demographic and clinical information was collected by chart review in June 2016 and March 2017. Associations with clinical sequelae were analyzed using the chi-square test, t test, and multivariate logistic regression. RESULTS: From January 2015 to March 2017, 329 EVD survivors were evaluated at ELWA. Most survivors experienced myalgia/arthralgia (73%; n = 239) and headache (53%; n = 173). The length of time from Ebola Treatment Unit (ETU) discharge to first clinic visit ranged from 0 to 30 months. Many visits (30%) occurred 24 or more months after ETU discharge. The proportion of visits for headache, weight loss, joint pain, visual problems, insomnia, fatigue, memory loss, decreased libido, depression, and uveitis decreased over time. More men than women had visits for depression; however, these differences were not significant. Symptom prevalence differed in adults and children; significantly more adults experienced myalgia/arthralgia (77% vs 44%), visual problems (41% vs 12%), post-EVD-related musculoskeletal pain (42% vs 15%), and insomnia (17% vs 2%). CONCLUSIONS: EVD survivors frequented ELWA for EVD-related symptoms many months after ETU discharge, indicating a long-term need for care. Reported symptoms changed over time, which may reflect eventual resolution of some sequelae.
BACKGROUND: The Eternal Love Winning Africa (ELWA) Clinic was the first clinic to provide free, comprehensive care to Ebola virus disease (EVD) survivors in Liberia. The objectives of this analysis were to describe the demographics and symptoms of EVD survivors at ELWA from January 2015 through March 2017 and to identify risk factors for development of sequelae. METHODS: Patients' demographic and clinical information was collected by chart review in June 2016 and March 2017. Associations with clinical sequelae were analyzed using the chi-square test, t test, and multivariate logistic regression. RESULTS: From January 2015 to March 2017, 329 EVD survivors were evaluated at ELWA. Most survivors experienced myalgia/arthralgia (73%; n = 239) and headache (53%; n = 173). The length of time from Ebola Treatment Unit (ETU) discharge to first clinic visit ranged from 0 to 30 months. Many visits (30%) occurred 24 or more months after ETU discharge. The proportion of visits for headache, weight loss, joint pain, visual problems, insomnia, fatigue, memory loss, decreased libido, depression, and uveitis decreased over time. More men than women had visits for depression; however, these differences were not significant. Symptom prevalence differed in adults and children; significantly more adults experienced myalgia/arthralgia (77% vs 44%), visual problems (41% vs 12%), post-EVD-related musculoskeletal pain (42% vs 15%), and insomnia (17% vs 2%). CONCLUSIONS: EVD survivors frequented ELWA for EVD-related symptoms many months after ETU discharge, indicating a long-term need for care. Reported symptoms changed over time, which may reflect eventual resolution of some sequelae.
Authors: Margaret E Kruk; Peter C Rockers; Elizabeth H Williams; S Tornorlah Varpilah; Rose Macauley; Geetor Saydee; Sandro Galea Journal: Bull World Health Organ Date: 2010-07-01 Impact factor: 9.408
Authors: K Kibadi; K Mupapa; K Kuvula; M Massamba; D Ndaberey; J J Muyembe-Tamfum; M A Bwaka; A De Roo; R Colebunders Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226
Authors: John G Mattia; Mathew J Vandy; Joyce C Chang; Devin E Platt; Kerry Dierberg; Daniel G Bausch; Tim Brooks; Sampha Conteh; Ian Crozier; Robert A Fowler; Amadu P Kamara; Cindy Kang; Srividya Mahadevan; Yealie Mansaray; Lauren Marcell; Gillian McKay; Tim O'Dempsey; Victoria Parris; Ruxandra Pinto; Audrey Rangel; Alex P Salam; Jessica Shantha; Vanessa Wolfman; Steven Yeh; Adrienne K Chan; Sharmistha Mishra Journal: Lancet Infect Dis Date: 2015-12-23 Impact factor: 25.071
Authors: Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou Journal: Emerg Infect Dis Date: 2014-10 Impact factor: 6.883
Authors: Patrick Younan; Mathieu Iampietro; Andrew Nishida; Palaniappan Ramanathan; Rodrigo I Santos; Mukta Dutta; Ndongala Michel Lubaki; Richard A Koup; Michael G Katze; Alexander Bukreyev Journal: mBio Date: 2017-09-26 Impact factor: 7.867
Authors: Janet T Scott; Foday R Sesay; Thomas A Massaquoi; Baimba R Idriss; Foday Sahr; Malcolm G Semple Journal: Emerg Infect Dis Date: 2016-04 Impact factor: 6.883
Authors: Ionara Rabelo; Virginia Lee; Mosoka P Fallah; Moses Massaquoi; Iro Evlampidou; Rosa Crestani; Tom Decroo; Rafael Van den Bergh; Nathalie Severy Journal: Front Public Health Date: 2016-07-04
Authors: Sam Tozay; William A Fischer; David A Wohl; Kayla Kilpatrick; Fei Zou; Edwina Reeves; Korto Pewu; Jean DeMarco; Amy James Loftis; Katie King; Donald Grant; John Schieffelin; Galakpai Gorvego; Henrietta Johnson; Tonia Conneh; Gerald Williams; Julie A E Nelson; David Hoover; Darrius McMillian; Carson Merenbloom; Darrell Hawks; Karine Dube; Jerry Brown Journal: Clin Infect Dis Date: 2020-10-23 Impact factor: 9.079
Authors: Shabir Ahmad Dar; Syed Quibtiya Khurshid; Zaid Ahmad Wani; Aaliya Khanam; Inaamul Haq; Naveed Nazir Shah; Mir Shahnawaz; Hena Mustafa Journal: PLoS One Date: 2020-11-30 Impact factor: 3.240
Authors: Simeon Joel Zürcher; Philipp Kerksieck; Christine Adamus; Christian Markus Burr; Anja I Lehmann; Flavia Katharina Huber; Dirk Richter Journal: Front Public Health Date: 2020-11-11